|
In order to view this program you must log in. If you do not have an account, please register for one.
Viewing the webcast requires use of the free RealPlayer. 
If you are having problems viewing the program, please check out our technical support section.
|
| Credits | 1.00 |
| Release Date | 9/21/2007 |
| Termination Date | 9/21/2010 |
| Cost |
$25.00 to view the program and complete a post test for CME credit. To purchase this program please log in.
|
| Description | According to the National Institutes of Health, Multiple myeloma is a cancer that begins in plasma cells. Myeloma is hard to cure. Treatment may help control symptoms and complications. |
| Accreditation Statement | The Ohio State University Medical Center, Center for Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Ohio State University Medical Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| Author | Craig Hofmeister, MD |
| Objectives | Upon completion of this educational activity, the particpant will be able to: 1.) Recognize how to diagnose different plasma cell dyscrasias and differentiate them from other lymphoproliferative disorders. 2.) Interpret the eligibility and purpose of hematopoietic stem cell transplantation for multiple myeloma. |
| Audience | This course is designed for physicians. |
| Estimated Time to Complete | 1 Hour |
